Patent and FDA Strategies for Psychedelics, Psilocybin, and Cannabinoids
Magic mushrooms and pot. Yes, currently people use them for illicit reasons. But the compounds in them are now being investigated for typical pharmaceutical therapeutic properties. And how can investigators protect that R&D investment? We look at some strategies relating to psilocybin (the prime compound in magic mushrooms) and cannabidiol (CBD) found in pot to […]
Patent Appeals to the Federal Circuit Court of Appeals
The U.S. Court of Appeals for the Federal Circuit (CAFC) has exclusive jurisdiction over patent law appeals. That means that it is the sole appeals court for appeals out of the Patent Office and out of the federal trial courts. An appeals court is exactly that; a court of appeals, not another court of first […]
Litigating in the COVID Environment – Lessons Learned
Obviously the coronavirus pandemic has affected and continues to affect all aspects of the economy. The legal industry is no different. We are IP and FDA litigators. To this end, we can share some our insights on effective litigation during this pandemic. Lawsuits Have Not Decreased Our work is primarily in the fields of IP, […]
Upadhye Tang LLP Announces Name Change and Launches New Website As Innovative IP/FDA law firm
Upadhye Tang LLP announces its name change from Upadhye Cwik LLP. We launched Upadhye Cwik LLP in June 2019. Due to the untimely passing of named partner Joe Cwik in Feb. 2020, we now announce our name change to Upadhye Tang LLP. All contact information and our website (https://ipfdalaw.com) remains the same. The firm started […]
Microbiome and IP Issues in the Microbiome
Not All Types of IP Are Created Equal When It Comes to Patent Protection Protecting intellectual property (IP) is a priority for companies in the life sciences industry due to the significant revenue potential. But not all types of IP are created equal when it comes to patent protection. To be patentable, a product must […]
Coronavirus Cured? FDA/FTC Warning Letters
FDA/FTC Warning Letters Although discovering a cure for COVID-19 would certainly be welcome news, any current mention of a cure or vaccine is more likely to be fake news. Furthermore, with economic ramifications and health concerns affecting the entire global population, anyone making false claims about their product’s ability to treat or cure this deadly disease may […]
Patent Acquisition and Patent Litigation in Economic Downturn Times
How Companies Respond To An Economic Downturn During an economic downturn, companies typically respond in one of two ways. They either conserve limited cash resources, or they use the downturn as an opportunity to invest those limited resources in tomorrow. In this article, we discuss patent applications and patent enforcement and the issues involved in […]
Force Majeure Clause & Other Defenses in Contract Law Because of Covid-19
The Global Impact of Covid-19 Cannot Be Understated The global impact of Covid-19 cannot be understated. Businesses are shut, employees are at home, and the supply chain is breaking. What rights do parties in a contract have because of the Covid-19 impact? Force majeure clauses and other principles of contract law are discussed here. Covid-19 […]
State Drug Price Transparency Laws – Avoiding Penalties and Navigating the Current Climate
Avoiding Penalties and Navigating the Current Climate In response to concerns about the increase in pharmaceutical drug pricing, many States are taking legislative action to increase price transparency and also to curb further increases. Because no federal legislation exists to control these price increases, States are taking their own action. Many States passed new legislation […]
Holiday Season IP Issues
Holiday Season IP Issues The holidays are a season of joy, celebration, and time spent with family and friends. Of course, in recent decades, the holidays have also become synonymous with Black Friday sales, consumers fighting over popular products, and a general feeling of stress. This demand for competitively-priced, exciting new products means that companies […]
